VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies. (2019)
Attributed to:
Tracking hydrogel therapeutics using quantitative whole-body imaging
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2196/13696
PubMed Identifier: 31579027
Publication URI: http://europepmc.org/abstract/MED/31579027
Type: Journal Article/Review
Volume: 8
Parent Publication: JMIR research protocols
Issue: 10
ISSN: 1929-0748